A novel regulatory element between the human FGA and FGG genes

Summary

High circulating fibrinogen levels correlate with cardiovascular disease (CVD) risk. Fibrinogen levels vary between people and also change in response to physiological and environmental stimuli. A modest proportion of the variation in fibrinogen levels can be explained by genotype, inferring that variation in genomic sequences that regulate the fibri-nogen genes (FGA, FGB and FGG) may affect hepatic fibrinogen production and perhaps CVD risk. We previously identified a conserved liver enhancer in the fibrinogen gene cluster (CNC12), between FGB and FGA. Genome-wide Chromatin immunoprecipitation-sequencing (ChIP-seq) demonstrated that transcription factors which bind fibrinogen gene promoters also interact with CNC12, as well as two potential fibrinogen enhancers (PFE), between FGA and FGG. Here we show that one of the PFE sequences has potent hepatocyte enhancer activity. Using a luciferase reporter gene system, we found that PFE2 enhances minimal promoter- and FGA promoter-driven gene expression in hepatoma cells, regardless of its orientation with respect to the promoters. A region within PFE2 bears a short series of conserved nucleotides which maintain enhancer activity without flanking sequence. We also demonstrate that PFE2 is a liver enhancer in vivo, driving enhanced green fluorescent protein expression in transgenic zebrafish larval livers. Our study shows that combining public domain ChIP-seq data with in vitro and in vivo functional tests can identify novel fibrinogen gene cluster regulatory sequences. Variation in such elements could affect fibrinogen production and influence CVD risk.

Keywords

Fibrinogen - gene regulation - regulatory element - enhancer

• References

• 1 Danesh J, Lewington S, Thompson SG. et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809.
• 2 de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36: 7-17.
• 3 Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol 2011; 73: 503-514.
• 4 Machlus KR, Cardenas JC, Church FC. et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 2011; 117: 4953-4963.
• 5 Ariens RA. Elevated fibrinogen causes thrombosis. Blood 2011; 117: 4687-4688.
• 6 Otto JM, Grenett HE, Fuller GM. The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J Cell Biol 1987; 105: 1067-1072.
• 7 Fuller GM, Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann NY Acad Sci 2001; 936: 469-479.
• 8 Fort A, Borel C, Migliavacca E. et al. Regulation of fibrinogen production by microRNAs. Blood 2010; 116: 2608-2615.
• 9 Humphries SE, Ye S, Talmud P. et al. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15: 96-104.
• 10 Prabhakar S, Poulin F, Shoukry M. et al. Close sequence comparisons are sufficient to identify human cisregulatory elements. Genome Res 2006; 16: 855-863.
• 11 Pennacchio LA, Ahituv N, Moses AM. et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature 2006; 444: 499-502.
• 12 Visel A, Blow MJ, Li Z. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457: 854-858.
• 13 Fort A, Fish RJ, Attanasio C. et al. A liver enhancer in the fibrinogen gene cluster. Blood 2011; 117: 276-282.
• 14 Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011; 144: 327-339.
• 15 Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 2011; 12: 283-293.
• 16 Kent WJ, Sugnet CW, Furey TS. et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
• 17 Birney E, Stamatoyannopoulos JA, Dutta A. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
• 18 Blanchette M, Kent WJ, Riemer C. et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 2004; 14: 708-715.
• 19 Siepel A, Bejerano G, Pedersen JS. et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005; 15: 1034-1050.
• 20 Fish RJ, Vorjohann S, Bena F. et al. Developmental expression and organisation of fibrinogen genes in the zebrafish. Thromb Haemost 2012; 107: 158-166.
• 21 Cullen KE, Kladde MP, Seyfred MA. Interaction between transcription regulatory regions of prolactin chromatin. Science 1993; 261: 203-206.
• 22 Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science 2002; 295: 1306-1311.
• 23 de Wit E, de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev 2012; 26: 11-24.
• 24 Dehghan A, Yang Q, Peters A. et al. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2009; 02: 125-133.
• 25 Hamsten A, de Faire U, Walldius G. et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 02: 3-9.
• 26 Meade TW, Mellows S, Brozovic M. et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537.
• 27 Ridker PM, Vaughan DE, Stampfer MJ. et al. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
• 28 de Lange M, Snieder H, Ariens RA. et al. The genetics of haemostasis: a twin study. Lancet 2001; 357: 101-105.
• 29 Fish RJ, Neerman-Arbez M. Fibrinogen gene regulation. Thromb Haemost 2012; 108: 419-426.